Log In
BCIQ
Print this Print this
 

Versatis

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionMedicated plaster containing 5% lidocaine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat neuropathic pain associated with previous herpes zoster infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today